Arena Pharmaceuticals (ARNA:NASDAQ) Annual Reports & Investor Relations Material

Overview

Arena Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that specializes in developing oral drugs for a variety of therapeutic areas, including cardiovascular, central nervous system, inflammatory, and metabolic diseases. Additionally, the company focuses on discovering small molecule drug candidates that target G protein-coupled receptors.

Annual Reports

Frequently Asked Questions

What is Arena Pharmaceuticals's ticker?

Arena Pharmaceuticals's ticker is ARNA

What exchange is Arena Pharmaceuticals traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Arena Pharmaceuticals's headquarters?

They are based in San Diego, California

How many employees does Arena Pharmaceuticals have?

There are 201-500 employees working at Arena Pharmaceuticals

What is Arena Pharmaceuticals's website?

It is arenapharm.com

What type of sector is Arena Pharmaceuticals?

Arena Pharmaceuticals is in the Healthcare sector

What type of industry is Arena Pharmaceuticals?

Arena Pharmaceuticals is in the Biotechnology industry

Who are Arena Pharmaceuticals's peers and competitors?

The following five companies are Arena Pharmaceuticals's industry peers:

- Seagen

- Siren Gold Limited

- Guardant Health

- Agios Pharmaceuticals

- American Virtual Cloud Technologies, Inc.